TNF and rheumatoid arthritis: Additionally, both invasive and transcutaneous devices have shown some success in treating inflammatory conditions, like rheumatoid arthritis, by reducing mouse and human serum levels of TNF, IL-6, and IL-1β (Hong et al., 2019; Addorisio et al., 2019).